[go: up one dir, main page]

Isac, 2022 - Google Patents

Characterisation of the unfolded protein response in prostate cancer, and investigation of the ATF6 interactome using a modified mammalian expression system.

Isac, 2022

View PDF
Document ID
264969906936613305
Author
Isac A
Publication year

External Links

Snippet

Prostate cancer (PCa) cells grow in an environment which is known to cause endoplasmic reticulum (ER) stress. This activates a process called the unfolded protein response (UPR) which PCa utilises in order to survive and adapt to the adverse environmental conditions …
Continue reading at repository.essex.ac.uk (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
EP2641610A2 (en) Anticancer composition containing gkn 1
Isac Characterisation of the unfolded protein response in prostate cancer, and investigation of the ATF6 interactome using a modified mammalian expression system.
TORRES CIBLAGE PHARMACOLOGIQUE DU PHÉNOTYPE SOUCHE DES CELLULES CANCÉREUSES OVARIENNES PAR L’ÉPIGALLOCATÉCHINE GALLATE
Cheung p38 Mitogen-Activated Protein Kinase Inhibition in Castration-Resistant Prostate Cancer
Adamson Identifying regulatory mechanisms of androgen receptor variants by DNA-PKcs
Werner et al. Alcoholic pancreatitis: detailed characterisation of microcirculatory disturbances and leukocyte adhesion
Neri et al. Hemoconcentration as an early marker of severity of acute pancreatitis
Gu Membrane androgen receptor activation triggers pro-apoptotic responses in vitro and in vivo and blocks migration in colon cancer
Ni Role of GRP78 and its novel cytosolic isoform GRP78va in regulating the unfolded protein response in cancer
Cuthbertson et al. Hyperbaric oxygen reduces severity and improves survival in acute pancreatitis
Hackert et al. Platelet inhibition reduces tissue damage in acute pancreatitis
Szepessy et al. An Evolutionary Dilemma: Digestion Versus Pancreatitis. the Positively-Selected Arg101 Stimulates Autoactivation of Human Cationic Trypsinogen
Pap et al. Bile Duct Obstruction Caused by Biliary Mucin-producing Papillary Neoplasm Similar to IPMN of the Pancreas
Neoptolemos et al. Phase III Randomised Comparison of Gemcitabine (GEM) with Gemcitabine Plus Capecitabine (GEM-CAP) in Patients With Advanced Pancreatic Cancer
Pezzilli et al. The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire
Solomon Vitamin D receptor activity is differentially affected by the co-regulator Hic-5 in prostate cancer and stromal cells
Lankisch et al. Asymptomatic Hyperamylasemia and/or Hyperlipasemia: Their Incidence, Causes and Clinical Impact
Sahin-Tóth et al. Trypsinogen isoforms in the normal mouse pancreas
Urrutia et al. Is the Retinoblastoma Minus Mouse A Useful Genetically Engineered Model to Study Pancreatic Cancer?
Ujiki et al. Pancreatic cancer cell cycle arrest and apoptosis are induced by a novel depsipeptide sansalvamide analogue
Ougolkov et al. NUCLEAR ACCUMULATION OF ACTIVE GSK-3β CONTRIBUTES TO NFκB-MEDIATED PANCREATIC CANCER CELL SURVIVAL AND PROLIFERATION
Truty et al. COMPREHENSIVE ANALYSIS OF THE SP/KLF FAMILY OF TRANSCRIPTION FACTORS IN THE TGF-BETA SIGNALING IN PANCREATIC CANCER CELLS
Fischer et al. CLASS I PI3K ISOFORMS δ AND γ REGULATE KEY RESPONSES OF CERULEIN-INDUCED PANCREATITIS. PI3Kδ IS NECESSARY FOR TRYPSIN ACTIVATION
Nodit et al. ENDOSCOPIC ULTRASOUND GUIDED BROAD PANEL MICRODISSECTION BASED GENOTYPING DIFFERENTIATES MALIGNANT AND BENIGN PANCREATIC MASSES
Rocha et al. EFFECT OF RADIOLOGIC INTERVENTION ON MORTALITY IN NECROTIZING PANCREATITIS